Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
📊
AI Sentiment
Positive
7/10
- Home
- TWST
as of 02-24-2026 9:38am EST
$47.08
$0.83
-1.73%
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 3.0B | IPO Year: | 2018 |
| Target Price: | $48.75 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.50 | EPS Growth: | 63.89 |
| 52 Week Low/High: | $23.30 - $57.88 | Next Earning Date: | 05-04-2026 |
| Revenue: | $376,572,000 | Revenue Growth: | 20.32% |
| Revenue Growth (this year): | 18.89% | Revenue Growth (next year): | 15.28% |
| P/E Ratio: | -94.74 | Index: | N/A |
| Free Cash Flow: | -75632000.0 | FCF Growth: | N/A |
Stock Insider Trading Activity of Twist Bioscience Corporation (TWST)
Finn Patrick John
Sell
President and COO
TWST Feb 13, 2026
Avg Cost/Share
$50.04
Shares
1,750
Total Value
$87,571.75
Owned After
306,250
SEC Form 4
CHESS ROBERT
Sell
Director
TWST Feb 13, 2026
Avg Cost/Share
$48.26
Shares
2,184
Total Value
$105,402.02
Owned After
21,084
SEC Form 4
Finn Patrick John
Sell
President and COO
TWST Feb 12, 2026
Avg Cost/Share
$50.23
Shares
3,500
Total Value
$175,787.50
Owned After
306,250
SEC Form 4
Laponis Adam
Sell
Chief Financial Officer
TWST Feb 12, 2026
Avg Cost/Share
$50.00
Shares
7,000
Total Value
$350,000.00
Owned After
130,031
SEC Form 4
Cho Dennis
Sell
See Remarks
TWST Feb 11, 2026
Avg Cost/Share
$49.93
Shares
5,000
Total Value
$249,650.00
Owned After
138,581
SEC Form 4
JOHANNESSEN JAN
Sell
Director
TWST Feb 6, 2026
Avg Cost/Share
$47.91
Shares
2,200
Total Value
$105,394.74
Owned After
17,754
SEC Form 4
WERNER ROBERT F.
Sell
Chief Accounting Officer
TWST Feb 4, 2026
Avg Cost/Share
$45.65
Shares
7,000
Total Value
$319,536.00
Owned After
58,738
SEC Form 4
Leproust Emily M.
Sell
Chief Executive Officer
TWST Feb 3, 2026
Avg Cost/Share
$46.58
Shares
5,001
Total Value
$232,926.58
Owned After
869,312
SEC Form 4
Green Paula
Sell
SVP of Human Resources
TWST Feb 3, 2026
Avg Cost/Share
$46.58
Shares
1,194
Total Value
$55,611.74
Owned After
165,445
SEC Form 4
Cho Dennis
Sell
See Remarks
TWST Feb 3, 2026
Avg Cost/Share
$46.58
Shares
1,099
Total Value
$51,187.02
Owned After
138,581
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Finn Patrick John | TWST | President and COO | Feb 13, 2026 | Sell | $50.04 | 1,750 | $87,571.75 | 306,250 | |
| CHESS ROBERT | TWST | Director | Feb 13, 2026 | Sell | $48.26 | 2,184 | $105,402.02 | 21,084 | |
| Finn Patrick John | TWST | President and COO | Feb 12, 2026 | Sell | $50.23 | 3,500 | $175,787.50 | 306,250 | |
| Laponis Adam | TWST | Chief Financial Officer | Feb 12, 2026 | Sell | $50.00 | 7,000 | $350,000.00 | 130,031 | |
| Cho Dennis | TWST | See Remarks | Feb 11, 2026 | Sell | $49.93 | 5,000 | $249,650.00 | 138,581 | |
| JOHANNESSEN JAN | TWST | Director | Feb 6, 2026 | Sell | $47.91 | 2,200 | $105,394.74 | 17,754 | |
| WERNER ROBERT F. | TWST | Chief Accounting Officer | Feb 4, 2026 | Sell | $45.65 | 7,000 | $319,536.00 | 58,738 | |
| Leproust Emily M. | TWST | Chief Executive Officer | Feb 3, 2026 | Sell | $46.58 | 5,001 | $232,926.58 | 869,312 | |
| Green Paula | TWST | SVP of Human Resources | Feb 3, 2026 | Sell | $46.58 | 1,194 | $55,611.74 | 165,445 | |
| Cho Dennis | TWST | See Remarks | Feb 3, 2026 | Sell | $46.58 | 1,099 | $51,187.02 | 138,581 |
Latest Twist Bioscience Corporation News
TWST Breaking Stock News: Dive into TWST Ticker-Specific Updates for Smart Investing
MT Newswires
Twist Bioscience Insider Sold Shares Worth $263,359, According to a Recent SEC Filing
📉
AI Sentiment
Negative
3/10
Business Wire
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
📈
AI Sentiment
Highly Positive
8/10
Compare TWST vs Leading Stocks
See how TWST stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TWST Twist Bioscience Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.